The results showed that the expression of ATF6 level did not associated with OS (P = 0.083; Fig. 5A), while colon cancer patients with strong expression of CIP2A showed significantly lower OS rates than those with weak expression (P < 0.001; Fig. 5B). The gene discussed is ATF6; the disease is malignant colon neoplasm.